Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter July 21, 2016

Biclonal plasma cell myeloma with the simultaneous appearance of both secretory lambda and nonsecretory kappa monoclonal light chains

  • Hyun Jung Gu , Sun Young Cho EMAIL logo , Juhie Lee EMAIL logo , Ji-Youn Sung and Tae Sung Park

Corresponding authors: Sun Young Cho, MD, PhD, Department of Laboratory Medicine, School of Medicine, Kyung Hee University, Kyung Hee Dae Ro 23, Dongdaemun-gu, Seoul 02447, Korea, Phone: +822 958 8674, Fax: +822 958 8609; and Juhie Lee, MD, PhD, Department of Pathology, School of Medicine, Kyung Hee University, Kyung Hee Dae Ro 23, Dongdaemun-gu, Seoul 02447, Korea, Phone: +822 9588741, Fax: +822 9588730

  1. Author contributions:All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT and Future Planning (NRF-2016R1A1A3A04004875) and a grant from Kyung Hee University in 2015 (KHU-20150833).

  3. Employment or leadership:None declared.

  4. Honorarium: None declared.

  5. Competing interests:The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Lee N, Lee H, Moon SY, Sohn JY, Hwang SM, Yoon OJ, et al. Adverse prognostic impact of bone marrow microvessel density in multiple myeloma. Ann Lab Med 2015;35:563–9.10.3343/alm.2015.35.6.563Search in Google Scholar

2. Cho SY, Yang HS, Kim YJ, Lee HJ, Park TS. Concomitant appearance of two false positive peaks with a true monoclonal one in a patient with plasma cell myeloma. Clin Chem Lab Med 2016;54:e7–10.10.1515/cclm-2015-0349Search in Google Scholar

3. Pradhan D, Arora P, Gami A, Kaur N. Immunoglobulin G kappa biclonal gammopathy associated with multiple myeloma, plasmacytoma and cast nephropathy. J Cancer Res Ther 2015;11:660.10.4103/0973-1482.139379Search in Google Scholar

4. González D, van der Burg M, Garcia–Sanz R, Fenton JA, Langerak AW, González M, et al. Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma. Blood 2007;110:3112–21.10.1182/blood-2007-02-069625Search in Google Scholar

5. Drayson M, Tang LX, Drew R, Mead GP, Carr-Smith H, Bradwell AR. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood 2001;97:2900–2.10.1182/blood.V97.9.2900Search in Google Scholar

6. Kyle RA, Robinson RA, Katzmann JA. The clinical aspects of biclonal gammopathies. Review of 57 cases. Am J Med 1981;71:999–1008.10.1016/0002-9343(81)90326-0Search in Google Scholar

7. Smith L, Barlogie B, Alexanian R. Biclonal and hypodiploid multiple myeloma. Am J Med 1986;80:841–3.10.1016/0002-9343(86)90625-XSearch in Google Scholar

Received: 2016-4-26
Accepted: 2016-6-17
Published Online: 2016-7-21
Published in Print: 2017-1-1

©2017 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 7.2.2023 from https://www.degruyter.com/document/doi/10.1515/cclm-2016-0364/html
Scroll Up Arrow